Eli Lilly inks cancer pact worth up to $5.9bn with Stipple Bio
Stipple plans to initiate a Phase I trial for an ADC for solid tumours in early 2027.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo